IQVIA艾昆纬：2025年欧盟HTA在行动-健康技术开发人员如何为成功的JCA做好准备报告（英文版）

The adoption of the Health Technology Assessment Regulation (HTAR) marks a transformative milestone in the European Union (EU) market access landscape. Health Technology Developers (HTDs) will need to adapt their approach to bringing new therapies to market while navigating important questions:How to balance EU Joint Clinical Assessment (JCA) against competing global evidentiary needs?How can EU HTA readiness be shaped in a way that brings organizational efficiency and benefits to other regio